AOD-9604 + CJC-1295 + Ipamorelin 12mg Blend
A triple-action fat loss and GH secretagogue blend combining AOD-9604 (6mg), CJC-1295 No DAC (3mg), and Ipamorelin (3mg) in a 12mg vial. Targets fat metabolism and pulsatile GH release.
Peptide Blend Directory
Pre-formulated multi-peptide blends with synergy guides and reconstitution protocols. 15 blends catalogued.
Cagrilintide + Semaglutide 10mg Blend
A dual GLP-1/amylin analogue weight loss blend combining Cagrilintide (5mg) and Semaglutide (5mg) in a 10mg vial. Mirrors the CagriSema mechanism studied in clinical trials for obesity treatment.
Semaglutide + AOD-9604 Weight Loss Blend
A dual-mechanism fat loss research blend combining GLP-1 receptor agonism (appetite suppression, metabolic improvement) with targeted lipolytic activity from the HGH fragment AOD-9604.
Tesamorelin + Ipamorelin 10mg Blend
A GH secretagogue blend combining Tesamorelin (5mg) and Ipamorelin (5mg) in a 10mg vial. Tesamorelin is FDA-approved for visceral fat reduction. Together they target body composition and GH optimization.